Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders. [electronic resource]
Producer: 20160331Description: 30-7 p. digitalISSN:- 1600-0641
- Adult
- Aged
- Antiviral Agents -- administration & dosage
- Carbamates
- DNA, Viral -- genetics
- Drug Administration Schedule
- Drug Carriers
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Interferon-alpha -- administration & dosage
- Isoquinolines -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Pyrrolidines
- Recombinant Proteins -- administration & dosage
- Ribavirin -- administration & dosage
- Sulfonamides -- administration & dosage
- Treatment Outcome
- Valine -- analogs & derivatives
- Viral Load -- genetics
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.